Newsletters

Last Subjects Treated in Canadian Study of MDMA-Assisted Therapy for PTSD Phase 2 Studies Near Completion in Preparation for Phase 3 Clinical Trials November 9, 2015 As 2015 draws to a close, we are quickly …

MAPS Email Newsletter: Last Two Subjects Treated in Colorado Study of MDMA-Assisted Therapy for PTSD MAPS Public Benefit Corporation Purchases MDMA in Preparation for Phase 3 Trials October 20, 2015 “Psychedelic …

MAPS Email Newsletter: Enrollment Complete in Colorado Study of MDMA-Assisted Therapy for PTSD Pilot study publication wins award for being journal’s most cited paper of 2011 September 22, 2015 Day …

MAPS Email Newsletter: All Experimental Treatments Completed in Study for U.S. Veterans with PTSD Crowdfunding campaign raises $69,406 to expand Zendo Project psychedelic harm reduction services August …

MAPS Email Newsletter: Obama Administration Ends Obstructive Review Process for Marijuana Research Psychedelic harm reduction crowdfunding campaign almost halfway to our goal, ends July 23 July 10, 2015 …

MAPS Email Newsletter: First Three Participants Enroll in Study of MDMA-Assisted Therapy for Life-Threatening Illness Anxiety Front page of San Francisco Chronicle highlights MDMA therapy research June …

MAPS Email Newsletter: Final Subject Enrolled and Treated in Study for U.S. Veterans with PTSD Silicon Valley Gives Day raises over $11,700 for MDMA research at Stanford University May 9, 2015 MAPS staff …

MAPS Email Newsletter: MDMA Study Starts in San Francisco Bay Area; Paper Published in Scientific Journal PLUS: Watch the premiere of WEED 3 on CNN with Dr. Sanjay Gupta on Sunday, April 19, at 9pm ET …

MAPS Email Newsletter: DEA Approves California Trial of MDMA-Assisted Therapy for Anxiety Associated with Life-Threatening Illness MAPS receives award as one of reddit’s top 10 charities March 16, …

MAPS Email Newsletter: Planning for the Future of Psychedelic Medicine Canadian Study Treats First Subject; MAPS Forms Public Benefit Corporation February 14, 2015 Dear friends and supporters, The Trip …

MAPS Email Newsletter: First Clinical Psychedelic Therapy Trial in Canada in Over 40 Years Canadian MDMA-Assisted Therapy for PTSD Study Starts After 8-Year Effort January 9, 2015 Dear friends and supporters, …

MAPS Email Newsletter: MAPS Receives $2 Million from Colorado for Medical Marijuana Research MDMA Studies Continue to Progress December 18, 2014 Dear friends and supporters, MAPS has been awarded $2 million …